Loading...

World-Class Retina Care. Community-Based Caring.

New Clinical Trials at Texas Retina

Posted On May 29, 2024 / By / Posted in Blog

New Clinical Trials at Texas Retina

Over the past two decades, Texas Retina physicians have participated in more than 100 national clinical trials, offering our patients access to promising new treatments for a variety of retina conditions, including

read more
Posted On May 24, 2024 / By / Posted in Blog

Our Offices Will Close for Memorial Day

All Texas Retina Associates offices will be closed on Monday, May 27, in observance of Memorial Day. We remember and honor all who gave their lives in service to our country.

read more
Posted On May 23, 2024 / By / Posted in Blog

Dr. Abbey Presented Key Results of DAVIO 2 Clinical Trial for Wet AMD at Retina World Congress

At the recently held 2024 Retina World Congress Meeting, Texas Retina’s Dallas Director of Clinical Research Ashkan M. Abbey, MD, presented topline results from the DAVIO 2 clinical trial investigating EYP-1901 (Duravyu),

read more
Posted On May 15, 2024 / By / Posted in Blog

Celebrating Rita Vega’s 21+ Years of Service to Texas Retina

We continue to recognize Texas Retina team members who have served our practice for 20 years or more. Today, we honor Rita Vegas, who joined Texas Retina in 2002 and currently serves

read more
Posted On May 14, 2024 / By / Posted in Blog

May is Ocular Melanoma Awareness Month

Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina, we have been caring for ocular melanoma

read more
Posted On May 9, 2024 / By / Posted in Blog

Dr. Abbey Presents GALE Study Data at the Association for Research in Vision and Ophthalmology

At this year’s ARVO 2024, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), Texas Retina’s Dr. Abbey presented 36-month data from the GALE study of pegcetacoplan (brand

read more
Posted On May 7, 2024 / By / Posted in Blog

Texas Retina Associates Participating in Phase III Clinical Trial for Choroidal Melanoma

Under the leadership of principal investigator Timothy Fuller, MD, Texas Retina is now participating in the Phase III AU-011 clinical trial (CoMpass) for treatment of small choroidal (ocular) melanoma. Together with Aura

read more
Posted On May 3, 2024 / By / Posted in Blog

May is Healthy Vision Month: Take These 10 Steps to Protect Your Eyes

The National Eye Institute has designated May as Healthy Vision Month. It is the perfect time to learn how to protect your eyes and vision, and to encourage your family members to

read more
Posted On May 1, 2024 / By / Posted in Blog

Texas Retina Recognizes Debbie Krahl for 23 Years of Service

As we continue to celebrate our team members who have served Texas Retina for 20+ years, today we recognize Debbie Krahl, who currently serves as a Clinical Site Coordinator and Scribe in

read more